Loomis, CA Sprig Oral Health Technologies (Sprig), the dental products company that invented and produces pediatric Zirconia crowns, recently introduced two new products, a Mineral Trioxide Aggregate (MTA) and a retraction pellet solution, that help pediatric dentists around the world perfect procedure techniques and provide better results to their patients. The new products SmartMTA and HemeRx — are designed to provide young patients with reliable, biocompatible dental comfort for years after their use. Both products are featured in the August 2017 issue of Dental Product Shopper.
“For Sprig, the health of patients using our product is paramount, which is why we are constantly innovating to create the best biocompatible products on the market,” said Sprig CEO Brenda Hansen. “We are excited to unveil our SmartMTA and HemeRx because we feel both products add a level of ease and comfort to pediatric dental procedures that patients deserve.”
Sprig’s SmartMTA is an MTA that sets in just two and a half minutes, at least five times faster than other brands, saving valuable chair time and reducing material costs, making SmartMTA the most economical MTA on the market today. The fast set time allows for placement and final restoration in the same visit without the need for the second step of a liner.
“Many parents and dentists are becoming increasingly concerned with the use of toxic chemicals like formocresol, which is genotoxic and a known carcinogen that is still used in pulpotomies today. SmartMTA gives dentists and parents a smarter choice for children since it is made entirely from non-toxic materials designed to regenerate teeth back to health,” said Sprig Co-founder Dr. John Hansen.
SmartMTA is a truly non-staining MTA. Other brands may contain iron and bismuth oxide which improve radiopacity, but can stain over time. SmartMTA’s unique Calcium Zirconium Aluminate formula is inherently radiopaque so there is no need for potentially staining additives.
Sprig’s HemeRx retraction pellets deliver simple and superior hemostasis management for pediatric restorative procedures without leaving the notoriously unpleasant taste in children’s mouths. The HemeRx pellets contain 0.55mg of racemic epinephrine to deliver fast and profound hemostasis and gingival retraction and unlike ferric sulfate and aluminum chloride products, HemeRx won’t stain composite or Zirconia crowns and doesn’t run immediately on placement.
“Hemostasis is crucial for the longevity of our Zirconia and strip crowns, and our HemeRx offers simple hemostasis management with no risk of contamination for today’s adhesive and bioregenerative procedures,” said Sprig Co-founder Dr. Jeffery Fisher. “In developing both of these products, we have taken the needs of patients, parents, dentists and the environment into consideration and are extremely proud of the results.”
For nearly a decade Sprig has fought to bring the innovation today’s patients and professionals demand to pediatric dentistry. Adding HemeRx and SmartMTA to Sprig’s product lineup is another way that Sprig is helping the next generation receive next-generation care.
Sprig is pediatric dentistry’s leading technology and clinical education company. Since creating the first pediatric Zirconia crown, Sprig has continued to develop new and better solutions, from patented crown design that maximizes mechanical retention to a custom bur system that optimizes seating. Sprig leads the way in professional education through Sprig University, a celebrated continuing education program that teaches proprietary prep and seating techniques to help reduce chair time, alleviate clinical frustrations and grow dental practices. Sprig is constantly pushing the boundaries of pediatric dental innovation to ensure the next generation has next-generation care.
Learn more at SprigUSA.com.